The Enrichment Program supports the overall mission of the Penn DRC to prevent, treat, and cure diabetes. Its goals are to ensure that the DRC investigators from different departments and locations interact frequently and productively, that new scientific knowledge related to diabetes is disseminated to DRC investigators, and that the importance of diabetes research is recognized in the Philadelphia area. To achieve these goals, the Enrichment Program has the following Specific Aims: 1) Disseminate new diabetes research knowledge; 2) Foster interactions among DRC investigators; 3) Catalyze interdisciplinary interactions; 4) Foster the next generation of diabetes researchers; and 5) Increase awareness of the Penn DRC and the importance of diabetes research. The high scientific quality of the Enrichment Program's activities attracts not only Penn DRC members, but other members of the research community to lectures and events that increase awareness of Penn DRC cores and diabetes research. In addition, lay-oriented community events are hosted and designed to educate the public about the devastating epidemic of diabetes, and the importance of diabetes research at the Penn DRC and elsewhere to preventing and curing these diseases. In sum, the Enrichment Program of the Penn DRC plays a vital role in advancing the exchange of knowledge about diabetes, catalyzing interdisciplinary interactions and research in the scientific community it serves, and enhancing awareness of exciting diabetes research aimed at a cure at a time when the disease is rampant and increasingly threatening the health of people in Philadelphia and across the United States.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK019525-42
Application #
9490330
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
42
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Rickels, Michael R; Peleckis, Amy J; Dalton-Bakes, Cornelia et al. (2018) Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes. J Clin Endocrinol Metab 103:105-114
Guan, Dongyin; Xiong, Ying; Borck, Patricia C et al. (2018) Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes. Cell 174:831-842.e12
Jang, Cholsoon; Chen, Li; Rabinowitz, Joshua D (2018) Metabolomics and Isotope Tracing. Cell 173:822-837
Shoshkes-Carmel, Michal; Wang, Yue J; Wangensteen, Kirk J et al. (2018) Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature 557:242-246
Ibrahim, Fadia; Maragkakis, Manolis; Alexiou, Panagiotis et al. (2018) Ribothrypsis, a novel process of canonical mRNA decay, mediates ribosome-phased mRNA endonucleolysis. Nat Struct Mol Biol 25:302-310
Cooney, Laura G; Milman, Lauren W; Hantsoo, Liisa et al. (2018) Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertil Steril 110:161-171.e1
Condon, David E; Tran, Phu V; Lien, Yu-Chin et al. (2018) Defiant: (DMRs: easy, fast, identification and ANnoTation) identifies differentially Methylated regions from iron-deficient rat hippocampus. BMC Bioinformatics 19:31
Correnti, Jason M; Gottshall, Lauren; Lin, Annie et al. (2018) Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells. Sci Rep 8:12923
Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142
Qiu, Chengxiang; Huang, Shizheng; Park, Jihwan et al. (2018) Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med 24:1721-1731

Showing the most recent 10 out of 720 publications